Background-Evidence supporting the use of bioprostheses for heart valve replacement in young adults is accumulating.However, reoperation data, which may help guide clinical decision making in young patients, remains poorly defined in the literature. Methods and Results-We examined the need for reoperation in 3975 patients who underwent first-time bioprosthetic aortic valve replacement (AVR) (nϭ3152) or mitral valve replacement (MVR) (nϭ823). There were 895 patients below the age of 60 years at bioprosthesis implant (AVR, nϭ636; MVR, nϭ259